spiperone has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, D | 1 |
| Ma, N | 1 |
| Chen, L | 1 |
| Huang, J | 1 |
| Zhong, X | 1 |
| Birrell, MA | 1 |
| Crispino, N | 1 |
| Hele, DJ | 1 |
| Patel, HJ | 1 |
| Yacoub, MH | 1 |
| Barnes, PJ | 1 |
| Belvisi, MG | 1 |
2 other studies available for spiperone and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Verification of the role of spiperone in the treatment of COPD through bioinformatics analysis.
Topics: Adult; Blotting, Western; Female; Humans; Hydrolases; Male; Metabolic Networks and Pathways; Middle | 2021 |
Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD.
Topics: Animals; Asthma; Capillary Permeability; Capsaicin; Dopamine; Dopamine Agonists; Dopamine Antagonist | 2002 |